The Daily Pennsylvanian is the award-winning independent daily student newspaper of the University of Pennsylvania



AlphaThera was featured in a Daily Pennsylvanian article covering news of the recently awarded NIH $667,000 COVID-19 grant. The article discusses the partnership between AlphaThera and UPenn’s Targeted Imaging Therapeutics and Nanomedicine (Titan) Lab, highlighting how the collaboration flows from development of the ELISA assay toward eventual clinical testing of the assay. The article’s coverage goes on to discuss the benefits of AlphaThera’s novel approach to the COVID-19 ELISA assay, specifically emphasizing an increase in ELISA sensitivity and reduction in assay time.


The researchers in AlphaThera’s labs continue to work toward optimizing the COVID-19 assay technology for clinical testing. Read here about the specifics of the project.